The activity of γδ T cells against paediatric liver tumour cells and spheroids in cell culture

Characterisation of the Cell Line HC-AFW1 Derived from a Pediatric Hepatocellular Carcinoma

(2012) Sorin Armeanu-Ebinger et al.   PLoS One

Hepatoblastoma: recent developments in research and treatment

(2012) Dietrich von Schweinitz   Seminars in Pediatric Surgery

Clinical evaluation of autologous gamma delta T cell-based immunotherapy for metastatic solid tumours

(2011) A J Nicol et al.   BRITISH JOURNAL OF CANCER

Phase I/II study of adoptive transfer of γδ T cells in combination with zoledronic acid and IL-2 to patients with advanced renal cell carcinoma

(2011) Hirohito Kobayashi et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Epithelial cell adhesion molecule expression (CD326) in cancer: A short review

(2011) Carlo Patriarca et al.   CANCER TREATMENT REVIEWS

γδT Cells Cross-Link Innate and Adaptive Immunity inMycobacterium tuberculosisInfection

(2011) Serena Meraviglia et al.   Clinical & Developmental Immunology

Concentrations of EpCAM ectodomain as found in sera of cancer patients do not significantly impact redirected lysis and T-cell activation by EpCAM/CD3-bispecific BiTE antibody MT110

(2011) Silke Petsch et al.   mAbs

Apoptosis sensitizers enhance cytotoxicity in hepatoblastoma cells

(2011) Justus Lieber et al.   PEDIATRIC SURGERY INTERNATIONAL

γδ T-cell immunotherapy for lung cancer

(2011) Yukihiro Yoshida et al.   SURGERY TODAY

Successful Treatment of Childhood High-Risk Hepatoblastoma With Dose-Intensive Multiagent Chemotherapy and Surgery: Final Results of the SIOPEL-3HR Study

(2010) József Zsíros et al.   JOURNAL OF CLINICAL ONCOLOGY

High frequency of immature cells at diagnosis predicts high minimal residual disease level in childhood acute lymphoblastic leukemia

(2010) Martin Ebinger et al.   LEUKEMIA RESEARCH

Highly Efficient Elimination of Colorectal Tumor-Initiating Cells by an EpCAM/CD3-Bispecific Antibody Engaging Human T Cells

(2010) Ines Herrmann et al.   PLoS One

Phase II Study of the Human Anti-Epithelial Cell Adhesion Molecule Antibody Adecatumumab in Prostate Cancer Patients with Increasing Serum Levels of Prostate-Specific Antigen after Radical Prostatectomy

(2010) Norbert Marschner et al.   UROLOGIA INTERNATIONALIS

An open-label, randomized phase II study of adecatumumab, a fully human anti-EpCAM antibody, as monotherapy in patients with metastatic breast cancer

(2009) M. Schmidt et al.   ANNALS OF ONCOLOGY

Hepatic Stem-like Phenotype and Interplay of Wnt/β-Catenin and Myc Signaling in Aggressive Childhood Liver Cancer

(2008) Stefano Cairo et al.   CANCER CELL

EpCAM and  -Fetoprotein Expression Defines Novel Prognostic Subtypes of Hepatocellular Carcinoma

(2008) T. Yamashita et al.   CANCER RESEARCH

Isopentenyl Pyrophosphate-Activated CD56+    T Lymphocytes Display Potent Antitumor Activity toward Human Squamous Cell Carcinoma

(2008) A. A.Z. Alexander et al.   CLINICAL CANCER RESEARCH

Zoledronate facilitates large-scale ex vivo expansion of functional γδ T cells from cancer patients for use in adoptive immunotherapy*

(2008) M. Kondo et al.   CYTOTHERAPY

Vγ9Vδ2 T cell cytotoxicity against tumor cells is enhanced by monoclonal antibody drugs—Rituximab and trastuzumab

(2008) Hirotake Tokuyama et al.   INTERNATIONAL JOURNAL OF CANCER

Sorafenib in Advanced Hepatocellular Carcinoma

(2008) Josep M. Llovet et al.   NEW ENGLAND JOURNAL OF MEDICINE

Liver Tumors in Children

(2008) J. B. Litten et al.   ONCOLOGIST

Liver transplantation for hepatocellular carcinoma in children

(2007) Sinasi Sevmis et al.   PEDIATRIC TRANSPLANTATION